Oh, how hard it is to open the gate for sepsis trials: lessons from SCARLET.

Although SCARLET could not achieve its primary end-point, the conditions of this trial were different from that of clinical practice in Japan. The effectiveness of the anticoagulant therapy for septic disseminated intravascular coagulation should be examined further in future studies.